UAE
Testvox FZCO
Fifth Floor 9WC Dubai Airport Freezone
FDA Cybersecurity submission approval – 100% guaranteed
15 June 2026
5:55 MIN Read time 
BY
Divya Prakash
In the high-stakes world of medical device manufacturing, the phrase 100% guaranteed is often used as a siren song for frustrated regulatory affairs professionals. We want to know if the months we spend on penetration testing and threat modeling and documentation will get us a Substantial Equivalence or De Novo letter.
The FDA does not give us any guarantees. What they do give us is a roadmap that changes a lot. Since they released the 2023 Final Guidance on Cybersecurity in Medical Devices the rules are now legally required, not just recommended. Getting approval the first time is not about being lucky or knowing someone. It is about making sure our submission is good so the reviewer does not have any questions left.
If you want to be sure you will get approved you have to start thinking of cybersecurity as a part of our design not just something we add at the end. We have to think of cybersecurity as something that’s necessary, from the start not just a final touch.
What a Complete FDA Cybersecurity Submission Looks Like
A complete submission is more than just a vulnerability scan. The FDA expects a comprehensive Cybersecurity Management Plan that proves you have considered security at every stage of the Total Product Lifecycle (TPLC).
A gold-standard submission generally includes:
- The Software Bill of Materials (SBOM): This is no longer optional. You must provide a machine-readable inventory of every third-party component, library, and open-source snippet used in your device.
- Threat Modeling: The FDA wants to see how you think like an attacker. Your threat model should identify assets, threats, and vulnerabilities, and then map them to specific mitigations.
- Security Risk Management Plan: This bridges the gap between traditional safety risk (ISO 14971) and security risk. You must demonstrate that a security breach won’t lead to patient harm.
- Vulnerability Assessment and Penetration Testing: Raw data isn’t enough. You need to provide a summary of the testing performed, the tools used, and evidence that any “Critical” or “High” vulnerabilities were remediated.
- Post-Market Management Plan: You must explain how you will monitor for new threats once the device is in the hands of clinicians and patients.
The Most Common Reasons FDA Rejects Cybersecurity Documentation
Understanding why others fail is the fastest way to succeed. Most Refuse to Accept (RTA) or “Additional Information” (AI) requests stem from three main pitfalls:
1. The “Safety vs. Security” Confusion
Many teams assume that if a device is safe, it is secure. The FDA disagrees. A device might be safe from a hardware failure perspective, but if an unauthorized user can disable an alarm via a network port, it is a security failure. Failing to distinguish between these two in your risk documentation is a massive red flag.
2. Generic Threat Models
Reviewers are tired of seeing “templated” threat models that don’t reflect the actual architecture of the device. If your threat model for a cloud-connected infusion pump looks identical to one for a standalone diagnostic software, the FDA will immediately question your technical depth.
3. Missing SBOM Granularity
An incomplete SBOM is a common cause for rejection. If you list “Linux” but don’t specify the kernel version or the specific sub-libraries utilized, the reviewer cannot assess your vulnerability management strategy. Accuracy here is paramount.
How to Structure Your Submission for First-Pass Approval
To streamline the reviewer’s job, you should mirror the FDA’s own guidance structure. If they can find what they are looking for in five seconds, they are less likely to dig for reasons to say no.
- Executive Summary of Security: Start with a high-level narrative. Explain the device’s connectivity, the intended environment (e.g., home use vs. hospital network), and your overall security philosophy.
- The “Traceability Matrix” approach: Explicitly link your threats to your requirements, and your requirements to your verification tests. This “closed-loop” logic is exactly what auditors look for.
- User Documentation: Include the actual instructions you provide to the end-user regarding security. This includes how to set strong passwords, how to update the software, and how to recognize a security breach.
Responding to FDA Additional Information Requests on Cybersecurity
Receiving an AI request isn’t a failure; it’s an opportunity to clarify. However, how you respond determines the fate of your timeline.
Don’t be defensive. If the FDA asks why you didn’t use a specific encryption standard, don’t just say “we didn’t think it was necessary.” Instead, provide a technical justification backed by your threat model.
Provide “Delta” Documentation. When you update a document in response to a request, highlight the changes. Make it incredibly easy for the reviewer to see that you listened and implemented their feedback. If they ask for more testing, don’t argue—perform the test, document the results, and explain how it strengthens the device’s posture.
The Role of “Secure by Design” (SBD)
The secret to a 100% success rate isn’t in the writing; it’s in the building. “Secure by Design” means that security features are not “bolted on” at the end.
Principles of SBD for Medical Devices:
- Least Privilege: Every process and user should only have the minimum level of access required to function.
- Defense in Depth: If one layer of security fails (e.g., the firewall), is there another layer (e.g., encrypted data at rest) to protect the patient?
- Fail-Safe Defaults: If the device loses its connection or crashes, does it revert to a state that is safe for the patient?
The Hidden Cost of Non-Compliance
A delayed approval isn’t just a regulatory headache; it’s a massive financial burden. Every month your device sits in “AI status” is a month of lost revenue, increased R&D burn, and potential market capture by competitors.
Beyond the financials, there is the reputational risk. In the age of transparency, cybersecurity vulnerabilities are public knowledge. A device that is rejected for poor security documentation sends a message to hospital procurement departments that your company may not be ready for the modern digital healthcare ecosystem.
Building a Culture of Security
Ultimately, achieving a smooth FDA approval requires a cultural shift within your organization. Cybersecurity cannot be the sole responsibility of one “IT guy” or a single regulatory specialist.
It requires a “Security First” mindset across:
- Engineering: To build robust code and hardware.
- Quality Assurance: To ensure testing is rigorous and repeatable.
- Leadership: To allocate the budget and time necessary for deep security work.
Conclusion: Engineering Your Own Guarantee
You cannot promise that the FDA will approve something. You can do things to make it very likely. If you make sure your paperwork matches the rules and you are completely honest about the problems and you build safety into your device from the start you can avoid the things that usually cause the FDA to say no.
The FDA is not trying to stop you. They want the thing you do: to make sure that medical devices are safe and work well so people are not hurt. Think of the paperwork you have to do as a way to show the FDA how you are keeping people safe and they will probably say yes to your device. The FDA and you want the thing, which is to help people, with medical devices that are safe.
ABOUT TESTVOX
Testvox is a software testing company help your product reach its full potential. Get full cycle testing for your mobile and web applications while ensuring all quality assurance standards are met... Read More
100+
Applications
Assured
Assured
5 Star Rating
5 Star Rating
“By participating in our release lifecycle, Testvox's standard QA process has helped us to launch quality products faster.”
Rima Hudaifa
Manager | Cadvil
Manager | Cadvil
